New insider Mclellan Philip D. claimed ownership of 5,549 shares (SEC Form 3)
$QDEL
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 11/15/2024 |
3. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 5,549 | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Non-Qualified Stock Options | (1) | 11/02/2030 | Common Stock | 1,678 | $248.41 | D | |
| Non-Qualified Stock Options | (2) | 02/01/2031 | Common Stock | 1,352 | $254 | D | |
| Non-Qualified Stock Options | (3) | 01/31/2032 | Common Stock | 4,507 | $103.36 | D | |
| Non-Qualified Stock Options | (4) | 04/26/2033 | Common Stock | 5,836 | $88.67 | D | |
| Non-Qualified Stock Options | (5) | 04/22/2034 | Common Stock | 9,714 | $39.08 | D | |
| Restricted Stock Units | (6) | (6) | Common Stock | 338 | (7) | D | |
| Restricted Stock Units | (8) | (8) | Common Stock | 420 | (7) | D | |
| Restricted Stock Units | (9) | (9) | Common Stock | 2,254 | (7) | D | |
| Restricted Stock Units | (10) | (10) | Common Stock | 1,693 | (7) | D | |
| Restricted Stock Units | (11) | (11) | Common Stock | 2,009 | (7) | D | |
| Restricted Stock Units | (11) | (11) | Common Stock | 634 | (7) | D | |
| Restricted Stock Units | (12) | (12) | Common Stock | 3,891 | (7) | D | |
| Restricted Stock Units | (13) | (13) | Common Stock | 9,713 | (7) | D | |
| Restricted Stock Units | (14) | (14) | Common Stock | 4,749 | (7) | D | |
| Explanation of Responses: |
| 1. Vested in full. |
| 2. 1,014 shares are vested in full; the remaining 338 shares will vest on February 1, 2025. |
| 3. 2,253 shares are vested in full: the remaining 2,254 shares will vest in equal installments on January 31, 2025 and January 31, 2026. |
| 4. 1,945 shares are vested in full; 1,945 shares will vest on April 26, 2025 and 1,946 shares will vest on April 26, 2026. |
| 5. 9,714 shares will vest in equal installments on April 22, 2025, April 22, 2026 and April 22, 2027. |
| 6. 338 shares will vest on February 1, 2025. |
| 7. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. |
| 8. 420 shares will vest on May 25, 2025. |
| 9. 2,254 shares will vest in equal installments on January 31, 2025 and January 31, 2026. |
| 10. 846 shares will vest on January 31, 2025 and 847 shares will vest on January 31, 2026. |
| 11. Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| 12. 1,945 shares will vest on April 26, 2025 and 1,946 shares will vest on April 26, 2026. |
| 13. 3,237 shares will vest on April 22, 2025; 6,476 shares will vest in equal installments on April 22, 2026 and April 22, 2027. |
| 14. 4,749 shares will vest on June 30, 2025. |
| Remarks: |
| Exhibit 24.1 - Power of Attorney |
| /s/ Jennifer Ahn, attorney-in-fact for Philip D. McLellan | 11/22/2024 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||